ArticleFrontiers in nutrition2026
Prehabilitative parenteral nutrition and surgery-related muscle loss in patients undergoing major upper gastrointestinal surgery: a single-centre observational cohort study.
Article in Frontiers in nutrition, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Surgery-related muscle loss (SRML) is common after major upper gastrointestinal (GI) surgery and is associated with worse recovery and survival, and prehabilitative parenteral nutrition (PN) has been proposed to attenuate it, yet data from Southeast Asian populations are absent. We set out to characterise perioperative muscle change and to test whether the amount of protein and energy delivered per kilogram body weight was associated with muscle preservation. Methods: We conducted a single-centre observational cohort study of 115 adults who underwent elective major upper GI surgery at Hospital Sultanah Aminah, Johor Bahru, and received 800 kcal/day premixed prehabilitative PN (38 g amino acids), as a supplement to oral or enteral intake, for 7 days before surgery. Body composition was measured by segmental bioimpedance analysis (InBody 770) at admission and on postoperative days (PODs) 3, 7, 30, and 90. The primary outcome was clinically relevant SRML, defined as a decrease in skeletal muscle mass (SMM) of 10% or more from admission to POD 7; 111 patients had an evaluable POD 7 measurement. Results: Patients had a median age of 61 years, 58.3% were male, 70.4% had malignant disease, and 19.1% were underweight; median total protein delivery (PN plus oral or enteral intake) was 1.4 g/kg/day. From admission to POD 7, SMM decreased by a mean of 2.6%, phase angle by 6.2% and body mass index by 3.1% (all Discussion: In a real-world prehabilitative PN cohort, clinically relevant muscle loss was relatively infrequent, but protein delivery was not independently associated with muscle preservation, consistent with anabolic resistance during surgical stress. The single-arm design precludes causal inference, and the narrow range of protein exposure may have left the study underpowered to detect a dose-response relationship. Controlled studies with contemporaneous non-PN comparators, wider exposure contrasts and functional endpoints are required.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.